Task: Answer the multiple choice question.
Question: Which drug has a 1.427\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CSCCC(NS(=O)(=O)c1cc(C(=O)O)ccc1Cl)C(=O)O
b CCC(CC)c1nnc(NC(=O)c2ccc(N3CCCC3=O)cc2)s1
Answer: b. CCC(CC)c1nnc(NC(=O)c2ccc(N3CCCC3=O)cc2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(CC)c1nnc(NC(=O)c2ccc(N3CCCC3=O)cc2)s1
CCC(CC)c1nnc(NC(=O)c2ccc(N3CCCC3=O)cc2)s1
4-(2-oxopyrrolidin-1-yl)-N-(5-pentan-3-yl-1,3,4-thiadiazol-2-yl)benzamide